CAS: 72093-03-9; 3-Chloro-2-Methylpyridine

该化合物是卤化的衍生物,其分子式为C6H6ClN.该化合物是有机合成的多用途中间体,特别是在制药和农用化学工业中.其氯和甲基替代成分可增强活性,能够有选择地发挥功能,生产更复杂的七环化合物.电子脱钩(氯)和电子施用(甲基)组的存在提供了平衡的电子特性,促进了多种化学变异.它通常用于交叉反应,核细胞代用品和活性药物成分的前体.其特征是其稳定性,高纯度和与一系列合成方法的兼容性,使它成为精密化学合成中有价值的建筑块.

结构式图片

相似化合物

72093-07-3 96439-98-4 1881320-96-2

欧盟法规

C&L通报

上下游产品

CAS号2402-77-9 2,3-二氯吡啶 | CAS号75-16-1 甲基溴化镁 | CAS号626-60-8 3-氯吡啶 | CAS号3512-76-3 3-chloro-2,6-di... | CAS号137778-09-7 (5-氯-6-甲基-2-吡啶基)甲醇 | CAS号137778-17-7 5-氯-6-甲基吡啶甲醛 | CAS号137778-19-9 5-chloro-6-meth... | CAS号60588-81-0 3-氯吡啶-2-甲醇 | CAS号206181-90-0 3-氯吡啶-2-甲醛 | CAS号57266-69-0 3-氯-2-吡啶甲酸

合成工艺路线路线简述

    📜(5-氯-6-甲基-2-吡啶基)甲醇置于selenium(Iv) Oxide,硝酸体系中,用 1,4-二氧六环,水 作为反应溶剂,化学反应 4.5H,反应生成 3-氯-2-甲基吡啶
    参考文献:Ban-Oganowska,Hanna; Talik,Tadeusz,Polish Journal Of Chemistry,1991,Vol. 65,# 2-3,P. 289-295
    标题:Ban-Oganowska,Hanna; Talik,Tadeusz,Polish Journal Of Chemistry,1991,Vol. 65,# 2-3,P. 289-295

    海关参考信息

    专利信息


    专利号:US-6867202-B1
    优先权日:1997-06-25
    标 题 :Treatment of insulin resistance
    发明人:CARPINO PHILIP ALBERT; CHIU CHARLES KWOK-FUNG; PAN LYDIA CODETTA; LEFKER BRUCE ALLEN; TREADWAY JUDITH LEE; ZAWISTOSKI MICHAEL PAUL
    权利人:PFIZER
    摘要:This invention is directed to methods of treating insulin resistance in a mammal which comprise administering an effective amount of a compound of formula I, n n nwhere the variables are defined in the specification, or the stereoisomeric mixtures, diastereomerically enriched, diastereomerically pure, enantiomerically enriched or enantiomerically pure isomers, or the pharmaceutically acceptable salts and prodrugs thereof to said mammal. The compounds of formula I are growth hormone secretagogues and as such are useful for increasing the level of endogenous growth hormone. In another aspect this invention provides certain intermediates which are useful in the synthesis of the foregoing compounds and certain processes useful for the synthesis of said intermediates and th compounds of formula I. This invention is further directed to methods comprising administering to a human or other animal a combination of a functional somatostatin antagonist such as an alpha-2 adrenergic agonist and a compound of formula I.

    专利号:US-2016318862-A1
    优先权日:2013-09-25
    标 题:Synthesis of delta 12-pgj3 and related compounds
    发明人:NICOLAOU KYRIACOS C; HERETSCH PHILIPP; HALE CHRISTOPHER R H; EL GHZAOUI ABDELLATIF EL MARROUNI; PULUKURI KIRAN KUMAR; YU RUOCHENG; GROVE CHARLES
    权利人:UNIV RICE WILLIAM M
    摘要:In one aspect, the present invention provides novel derivatives of Δ 12 -PGJ 3 and modular synthetic pathways to obtaining Δ 12 -PGJ 3 and derivatives thereof. In some aspects, the present derivatives of Δ 12 -PGJ 3 are useful as chemotherapeutic agents. The present disclosure also describes compositions of these derivatives as well as methods of use of the derivatives thereof.

    专利号:WO-2016071243-A1
    优先权日:2014-11-05
    标 题:Process for preparing halogenated alkenone ethers and their use in the synthesis of anthranilamide pesticides
    发明人:BENSON STEFAN; ZIERKE THOMAS; GOETZ ROLAND; WALK BERNHARD; DOMRES MONIKA
    权利人:BASF SE
    摘要:The present invention relates to a process for preparing a compound of formula (III) starting from the vinyl ether (IlIa) and the compound (IIIb) with a reagent (lllc) selected from the group of sulfonylhalides or sulfonylanhydrides, e.g. methanesulfonyl chloride or p-toluenesulfonyl chloride, in the presence of a base. The present invention relates also to processes comprising further preceding and/or subsequent reaction steps, leading to anthranilamide pesticides or to precursors for them.

    专利号:US-2005085555-A1
    优先权日:1997-08-21
    标 题:Composition, synthesis and therapeutic applications of polyamines
    发明人:MURPHY MICHAEL A; MALACHOWSKI MITCHELL R
    摘要:This invention relates to a process of synthesis and composition of open chain (ring), closed ring, linear branched and or substituted polyamines, polyamine derived tyrosine phosphatase inhibitors and PPAR partial agonists/partial antagonists via a series of substitution reactions and optimizing the bioavailability and biological activities of the compounds. Polyamines prevent the toxicty of neutoxins and diabetogenic toxins including paraquat, methyphenyl pyridine radical, rotenone, diazoxide, streptozotocin and alloxan. These polyamines can be to treat neurological, cardiovascular, endocrine acquired and inherited mitochondrial DNA damage diseases and other disorders in mammalian subjects, and more specifically to the therapy of Parkinson's disease, Alzheimer's disease, Lou Gehrig's disease, Binswanger's disease, Olivopontine Cerebellar Degeneration, Lewy Body disease, Diabetes, Stroke, Atherosclerosis, Myocardial Ischemia, Cardiomyopathy, Nephropathy, Ischemia, Glaucoma, Presbycussis, Cancer, Osteoporosis, Rheumatoid Arthritis, Inflammatory Bowel Disease, Multiple Sclerosis and as Antidotes to Toxin Exposure.

    专利号:US-2014057877-A1
    优先权日:2002-12-18
    标题:Therapeutic polyamine compositions and their synthesis
    发明人:MURPHY MICHAEL A; MALACHOWSKI MITCHELL R
    权利人:MURPHY MICHAEL A; MALACHOWSKI MITCHELL R
    摘要:This invention relates to a process of synthesis and composition of open chain (ring), closed ring, linear branched and or substituted polyamines, polyamine derived tyrosine phosphatase inhibitors and PPAR partial agonists/partial antagonists via a series of substitution reactions and optimizing the bioavailability and biological activities of the compounds. Polyamines prevent the toxicity of neurotoxins and diabetogenic toxins including paraquat, methyphenyl pyridine radical, rotenone, diazoxide, streptozotocin and alloxan. These polyamines can be utilized to treat neurological, cardiovascular, endocrine acquired and inherited mitochondrial DNA damage diseases and other disorders in mammalian subjects, and more specifically to the therapy of Parkinson's disease, Alzheimer's disease, Lou Gehrig's disease, Binswanger's disease, Olivopontine Cerebellar Degeneration, Lewy Body disease, Diabetes, Stroke, Atherosclerosis, Myocardial Ischemia, Cardiomyopathy, Nephropathy, Ischemia, Glaucoma, Presbycussis, Cancer, Osteoporosis, Rheumatoid Arthritis, Inflammatory Bowel Disease, Multiple Sclerosis and as Antidotes to Toxin Exposure.

    专利号:US-8853410-B2
    优先权日:2009-04-30
    标 题:Process for preparing substituted isoxazoline compounds and their precursors
    发明人:RACK MICHAEL; KOERBER KARSTEN; KAISER FLORIAN
    权利人:RACK MICHAEL; KOERBER KARSTEN; KAISER FLORIAN; BASF SE
    摘要:The present invention relates to a new method of preparing halogenated styrene compounds of formula (VIII) n nwhich are precursors in the process of synthesis of substituted isoxazoline compounds of formula (I)n n nwherein R 1 to R 5 , R 8 and R 9 are described as in the description.n n The present invention relates further to the synthesis of compounds of formula (I) starting from acetophenones. The desired styrenes of formula are prepared from the appropriate substituted acetophenone. Asides bromo anilines react with formoxime. Obtained oximes undergo a cycloaddition with the styrenes and give isoxazolines. Compounds of formula (I) can then be prepared in a palladium catalyzed carbonylative amination reaction of the isoxazolines.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1007/s11243-024-00630-6
    摘要:Unavane S, Patil R, Syed S, Jain HK. Exploring the therapeutic potential of copper and cobalt complexes as anticancer agents: a comprehensive review. Transit Met Chem. 2025 Feb 17;50(4):407–30. doi: 10.1007/s11243-024-00630-6.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知